膀胱肿瘤细胞外泌体circRNA_0013936促进PMN-MDSCs分化并上调FATP2和下调RIPK3介导免疫逃逸的机制研究。
批准号:
82073162
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
谭万龙
依托单位:
学科分类:
肿瘤免疫
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
谭万龙
中文摘要
多核型髓源性抑制细胞(PMN-MDSCs)是肿瘤微环境中重要的抑制性免疫细胞。在前期研究中,我们发现:肿瘤微环境中存在大量的PMN-MDSCs,且FATP2表达上调,RIPK3表达下调。目前,导致该现象的分子机制尚不清楚。我们通过预实验和高通量测序发现:膀胱肿瘤细胞外泌体中具有分子海绵作用的circRNA_0013936可能是介导上述现象的关键分子。我们推测:膀胱肿瘤细胞可能是通过外泌体circRNA_0013936调控miRNA-320a和miRNA-301b,启动相关信号通路,促进PMN-MDSCs分化并上调FATP2和下调RIPK3,进而介导肿瘤的免疫逃逸。本课题拟通过一系列细胞实验和动物实验,阐明膀胱肿瘤细胞通过外泌体circRNA_0013936促进PMN-MDSCs分化并上调FATP2和下调RIPK3介导免疫逃逸的新机制,为膀胱肿瘤的防治提供新的思路。
英文摘要
Multinuclear myeloid-derived suppressor cells (PMN-MDSCs) is an important suppressor immune cell in the tumor microenvironment. In our previous study, we found that the bladder tumor tissue was infiltrated with a large number of PMN-MDSCs. Moreover, the FATP2 expression was up-regulated, and the RIPK3 expression was down-regulated. At present, the molecular mechanism leading to this phenomenon is unclear. Through pre-experiment and sequencing technology, we found that circRNA_0013936, which has a molecular sponge effect in the bladder tumor cell-derived exosomes, may be a key molecule that mediates the above phenomenon. We speculate that bladder tumor cell-derived exosomal circRNA_0013936 may promote PMN-MDSCs differentiation, up-regulate FATP2 and down-regulate RIPK3 by regulating miRNA-320a and miRNA-301b and activating related signaling pathways, thereby mediating tumor immune escape. This study will perform a series of cell and animal experiments to elucidate a new mechanism by which bladder tumor cell-derived exosomal circRNA_0013936 mediates immune escape by promoting PMN-MDSCs differentiation, up-regulating FATP2 and down-regulating RIPK3. This study will provide new ideas for the prevention and treatment of bladder cancer.
背景:.多形核骨髓源性抑制细胞(PMN-MDSCs)是导致肿瘤免疫耐受和癌症免疫治疗失败的原因之一。在此,我们发现膀胱肿瘤细胞(BCa)来源的外泌体circRNA_0013936可以通过调节脂肪酸转运蛋白2(FATP2)和受体相互作用蛋白激酶3(RIPK3)的表达来增强PMN-MDSCs的免疫抑制活性。然而,其潜在机制在很大程度上仍然未知。.方法:分离BCa衍生的外泌体并用于一系列实验。RNA测序用于鉴定差异表达的环状RNA。通过Western印迹、免疫组织化学、免疫荧光、qRT-PCR、ELISA和流式细胞术等相关实验,证实并揭示circRNA_0013936促进PMN-MDSC免疫抑制活性的潜在分子机制。.重要研究结果:.富含BCa来源的外泌体的CircRNA_0013936可以促进PMN-MDSC中FATP2的表达并抑制RIPK3的表达。相关分子机制为:circRNA_0013936通过海绵状miR-320a和miR-301b促进FATP2的表达并抑制RIPK3的表达,这两种miRNA分别直接靶向JAK2和CREB1。最终,在PMN MDSC中,通过circRNA_0013936/miR-320a/JAK2通路上调FATP2,通过circRNA_00013936/miR-301b/CREB1通路下调RIPK3,从而显著抑制CD8+T细胞的功能。.主要的研究结论和科学意义:.BCa衍生的外泌体circRNA_0013936通过circRNA_00013936/miR-320a/JAK2通路上调FATP2,并通过circRNA-0013936/miR-301b-3p/CREB1通路下调PMN MDSC中的RIPK3,从而促进抑制性免疫。该研究成果将有助于为人类癌症的临床治疗找到新的靶点。
膀胱癌源性外泌体5’tRF-Ser-AGA通过上调去甲基化酶TET2促进Bregs细胞活化的机制研究
-
批准号:82372867
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:谭万龙
-
依托单位:
新型GM-CSF锚定的膀胱癌肿瘤干细胞疫苗的治疗作用及相关机制研究
-
批准号:81272844
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:谭万龙
-
依托单位:
国内基金
海外基金